Sight Sciences, Inc. (SGHT) research
Sight Sciences, Inc.- Sector
- Health Care
- Last price
- $8.53
- As of
Sight Sciences, Inc. (SGHT): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-10.
As of . Source: SEC EDGAR filings for SGHT. Method and limitations.
Share the SGHT intelligence card
See the full SGHT dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for SGHT on one page. Preview it with sample data, then open it live with a free account.
Preview the SGHT dossierActive signals for SGHT
- highCONSENSUS_SELL
3 tracked funds reduced SGHT this 2026Q2, institutional consensus
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 49.1%, EPS $-0.08 vs $-0.1573 estimate
- highINSTITUTIONAL_EXIT
Point72 Asset Management, L.P. cut 84% of SGHT (2026Q2)
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 71% of SGHT (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +170% to SGHT (2026Q2)
FREE, NO ACCOUNT
Every signal on SGHT, as it fires
You are seeing 5 of 12 signals recorded on SGHT since 2026-05-26.
The five above landed across 3 days. The other 7 were recorded on 3 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in SGHT (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| D. E. Shaw & Co., Inc.CUSIP 82657M105 · 2026Q2 | $1.5M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 82657M105 · 2026Q2 | $1.2M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 82657M105 · 2026Q2 | $1.2M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 82657M105 · 2026Q2 | $408K | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 82657M105 · 2026Q2 | $222K | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 82657M105 · 2026Q2 | $87K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, SGHT
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
SGHT against its peers
SGHT's operating margin of -48.0% ranks in the 6th percentile of 25 Health Care sub-industry peers, fiscal periods ending between 2025-08-31 and 2026-05-31.
| Metric | SGHT | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 77.4M USD | 568M USD | 2 | 25 |
| Gross margin | 86.2% | 58.4% | 96 | 13 |
| Operating margin | -48.0% | -3.7% | 6 | 25 |
| Net margin | -49.7% | -7.0% | 6 | 25 |
| Return on equity | -60.1% | -9.8% | 10 | 24 |
| P / E | n/a | 47.8x | n/a | 6 |
Peers (25): CERS, CCRN, EVH, FLGT, SLP, CTEV, ANGO, EHAB, AHCO, VREX, TALK, HSTM, BVS, PRCT, TDOC, CSTL, IRMD, GDRX, STAA, RXST, TNDM, OMDA, USPH, PNTG, AMN. Fiscal periods ending between 2025-08-31 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (SGHT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more SGHT signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to SGHTand get the insider, 13F, options, and confluence read in one view.